SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
(Rule 13d-101)
(Amendment No. 14)
Under the Securities Exchange Act of 1934
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)
Johns Manville Corporation (formerly Schuller Corporation)
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
478129-10-9
------------------------------------
(CUSIP Number)
Robert A. Falise, Esq.,
Manville Personal Injury Settlement Trust
375 Pound Ridge Road
Bedford, NY 10506
(914) 234-7400
-----------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
January 25, 1999
------------------------------------
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
[ ].
NOTE: Schedules files in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
<PAGE>
- -----------------------
CUSIP NO. - 478129-10-9
- -----------------------
- ------------------------------------------------------------
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Manville Personal Injury Settlement Trust;
I.R.S. Identification No. 43-1301883
- ------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [x]
- ------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------
4. SOURCE OF FUNDS
Not Applicable
- ------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ ]
- ------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
New York
- ------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 124,927,110
SHARES ----------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 0
EACH ----------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 124,927,110
WITH ----------------------------------------
10. SHARED DISPOSITIVE POWER
0
----------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
124,927,110
- ------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
|_|
- ------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
78.8%
- ------------------------------------------------------------
14. TYPE OF REPORTING PERSON
OO
- ------------------------------------------------------------
<PAGE>
- -----------------------
CUSIP NO. - 478129-10-9
- -----------------------
- ------------------------------------------------------------
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Robert A. Falise*
- ------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [x]
- ------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------
4. SOURCE OF FUNDS
Not Applicable
- ------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ ]
- ------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- ------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 0
SHARES ----------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 124,927,110
EACH ----------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 0
WITH ----------------------------------------
10. SHARED DISPOSITIVE POWER
124,927,110
----------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
124,927,110
- ------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
|_|
- ------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
78.8%
- ------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- ------------------------------------------------------------
- -------------
* Mr. Falise disclaims beneficial ownership of the shares of Common Stock owned
by the Trust.
<PAGE>
- -----------------------
CUSIP NO. - 478129-10-9
- -----------------------
- ------------------------------------------------------------
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Louis Klein, Jr.*
- ------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [x]
- ------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------
4. SOURCE OF FUNDS
Not Applicable
- ------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ ]
- ------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- ------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 0
SHARES ----------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 124,927,110
EACH ----------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 0
WITH ----------------------------------------
10. SHARED DISPOSITIVE POWER
124,927,110
----------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
124,927,110
- ------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
|_|
- ------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
78.8%
- ------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- ------------------------------------------------------------
- --------
* Mr. Klein disclaims beneficial ownership of all shares of Common Stock owned
by the Trust.
<PAGE>
- -----------------------
CUSIP NO. - 478129-10-9
- -----------------------
- ------------------------------------------------------------
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Frank J. Macchiarola*
- ------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [x]
- ------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------
4. SOURCE OF FUNDS
Not Applicable
- ------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ ]
- ------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- ------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 0
SHARES ----------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 124,927,110
EACH ----------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 0
WITH ----------------------------------------
10. SHARED DISPOSITIVE POWER
124,927,110
----------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
124,927,110
- ------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
|_|
- ------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
78.8%
- ------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- ------------------------------------------------------------
- ------------
* Mr. Macchiarola disclaims beneficial ownership of all shares of Common Stock
owned by the Trust.
<PAGE>
- -----------------------
CUSIP NO. - 478129-10-9
- -----------------------
- ------------------------------------------------------------
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Christian E. Markey, Jr.*
- ------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [x]
- ------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------
4. SOURCE OF FUNDS
Not Applicable
- ------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
[ ]
- ------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- ------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 0
SHARES ----------------------------------------
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 124,927,110
EACH ----------------------------------------
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 0
WITH ----------------------------------------
10. SHARED DISPOSITIVE POWER
124,927,110
----------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
124,927,110
- ------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
|_|
- ------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
78.8%
- ------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- ------------------------------------------------------------
- --------
* Judge Markey disclaims beneficial ownership of all shares of Common Stock
owned by the Trust.
<PAGE>
AMENDMENT NO. 14 TO SCHEDULE 13D
RELATING TO THE COMMON STOCK OF
JOHNS MANVILLE CORPORATION
This Amendment No. 14 (this "Amendment") filed by the Manville Personal
Injury Settlement Trust, a New York trust (the "Trust"), Robert A. Falise (a
Trustee of the Trust), Louis Klein, Jr. (a Trustee of the Trust), Frank J.
Macchiarola (a Trustee of the Trust) and Christian E. Markey, Jr. (a Trustee of
the Trust, and together with Messrs. Falise, Klein and Macchiarola, the
"Trustees"), amends and supplements the Statement on Schedule 13D relating to
the Trust's ownership of shares of Common Stock, par value $.01 per share (the
"Common Stock") of Johns Manville Corporation (formerly known as Schuller
Corporation), a Delaware corporation (the "Company") filed with the Securities
and Exchange Commission on December 8, 1988 by the Trust and its former trustees
and the previous amendments and supplements thereto (as previously amended and
supplemented, the "Schedule 13D"). Capitalized terms used but not defined herein
shall have the meaning ascribed to such terms in the Schedule 13D.
Item 2. IDENTITY AND BACKGROUND
(b) The address of the Trust is 375 Pound Ridge Road, Bedford, NY
10506.
Item 4. PURPOSE OF THE TRANSACTION.
Item 4 of the Schedule 13D is hereby further amended and supplemented
as follows:
On January 25, 1999, the Trust and the Company issued a press release
announcing that they were going to undertake a review of the strategic
alternatives available to maximize the Company's shareholder value, including
the possible sale or merger of the Company. The full text of the press release
is attached hereto as Exhibit 1.
If the current review does not lead to the sale or merger of the
Company, thereafter the Trust will continue to periodically evaluate its
investment in the Company in light of, among other things, the Company's
performance, the Trust's purposes and cash needs, and market conditions and may
determine to sell, from time to time, some or all of the shares of Common Stock
which the Trust presently holds through open market sales, privately negotiated
transactions or otherwise outside of a sale of the Company.
<PAGE>
Item 6. CONTRACTS, ARRANGEMENTS, UNDERTAKINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.
Item 6 of the Schedule 13D is hereby further amended and supplemented
by incorporating the response contained in Item 4 of this Amendment.
Item 7. MATERIAL TO BE FILED AS EXHIBITS.
Exhibit 1 -- Joint Press release of the Trust and Company
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of our knowledge and belief,
we certify that the information set forth in this Amendment is true, complete
and correct.
Dated: January 25, 1999
MANVILLE PERSONAL INJURY
SETTLEMENT TRUST
By: /s/ Robert A. Falise
----------------------------------
Name: Robert A. Falise
Title: Trustee
By: /s/ Louis Klein, Jr.
----------------------------------
Name: Louis Klein, Jr.
Title: Trustee
By: /s/ Frank J. Macchiarola
----------------------------------
Name: Frank J. Macchiarola
Title: Trustee
By: /s/ Christian E. Markey, Jr.
----------------------------------
Name: Christian E. Markey, Jr.
Title: Trustee
EXHIBIT 1
TEXT OF JOINT PRESS RELEASE
JOHNS MANVILLE TO EXPLORE STRATEGIC ALTERNATIVES
DENVER, Jan. 25, - Johns Manville Corporation (NYSE:JM) and its
majority shareholder, Manville Personal Injury Settlement Trust, today announced
that they will undertake a review of strategic alternatives available to
maximize JM's shareholder value. Such alternatives include the possible sale or
merger of the company. The Manville Trust owns approximately 79% of JM's
outstanding common stock.
No decision has been made to enter into any transaction or as to what form any
such transaction might take. Johns Manville is being advised by J.P. Morgan &
Co. Incorporated and the Manville Trust is being advised by Goldman, Sachs & Co.
Johns Manville Corporation is a leading manufacturer and marketer of
premium quality insulation and building products. The 141-year old Denver-based
company had 1998 sales of approximately $1.8 billion. Johns Manville employs
approximately 9,200 people and operates 54 manufacturing facilities in North
America, Europe and China. Additional information can be found at www.jm.com.
